Diclofenac rapid release - Nautilus Neurosciences
Alternative Names: PRO-571Latest Information Update: 02 Oct 2021
At a glance
- Originator Applied Pharma Research
- Developer Nautilus Neurosciences
- Class Antimigraines; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain